Subcutaneous Ustekinumab ( DrugBank: Ustekinumab )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
56	ベーチェット病	1

56. ベーチェット病

---

臨床試験数 : 76 /  薬物数 : 110 - (DrugBank : 32) / 標的遺伝子数 : 36 - 標的パスウェイ数 : 116

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02648581 (ClinicalTrials.gov)	June 14, 2017	21/12/2015	Efficacy and Safety of Ustekinumab, a Human Monoclonal Anti-IL-12/IL-23 Antibody, in Patients With Behçet Disease	A Phase 2 Open-Label Study to Evaluate the Efficacy and Safety of Ustekinumab, a Human Monoclonal Anti-IL-12/IL-23 Antibody, in Patients With Behçet Disease	Behçet Disease	Drug: Subcutaneous Ustekinumab	Assistance Publique - Hôpitaux de Paris	NULL	Completed	18 Years	N/A	All	16	Phase 2	France